These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 23403942)
1. Effects of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis. Winnick JJ; Ramnanan CJ; Saraswathi V; Roop J; Scott M; Jacobson P; Jung P; Basu R; Cherrington AD; Edgerton DS Am J Physiol Endocrinol Metab; 2013 Apr; 304(7):E747-56. PubMed ID: 23403942 [TBL] [Abstract][Full Text] [Related]
2. Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog. Edgerton DS; Basu R; Ramnanan CJ; Farmer TD; Neal D; Scott M; Jacobson P; Rizza RA; Cherrington AD Am J Physiol Endocrinol Metab; 2010 May; 298(5):E1019-26. PubMed ID: 20159854 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs. Shiota M; Jackson PA; Bischoff H; McCaleb M; Scott M; Monohan M; Neal DW; Cherrington AD Am J Physiol; 1997 Nov; 273(5):E868-79. PubMed ID: 9374671 [TBL] [Abstract][Full Text] [Related]
4. Direct regulation of glucose and not insulin on hepatic hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase type 1. Fan Z; Du H; Zhang M; Meng Z; Chen L; Liu Y Mol Cell Endocrinol; 2011 Feb; 333(1):62-9. PubMed ID: 21163329 [TBL] [Abstract][Full Text] [Related]
5. The 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against the insulin resistance and hepatic steatosis in db/db mice. Yuan X; Li H; Bai H; Zhao X; Zhang C; Liu H; Zhang Y; Zhao B; Wu Y; Liu J; Xiang Q; Feng B; Chu Y; Huang Y Eur J Pharmacol; 2016 Oct; 788():140-151. PubMed ID: 27242185 [TBL] [Abstract][Full Text] [Related]
6. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance. Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237 [TBL] [Abstract][Full Text] [Related]
7. In vivo activity of 11β-hydroxysteroid dehydrogenase type 1 in man: effects of prednisolone and chenodesoxycholic acid. Diederich S; Quinkler M; Mai K; Schöneshöfer M; Baehr V; Pfeiffer A; Oelkers W; Eigendorff E Horm Metab Res; 2011 Jan; 43(1):66-71. PubMed ID: 20925019 [TBL] [Abstract][Full Text] [Related]
8. 11beta-hydroxysteroid dehydrogenase type 1 and obesity. Morton NM; Seckl JR Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901 [TBL] [Abstract][Full Text] [Related]
9. Specific reduction of G6PT may contribute to downregulation of hepatic 11β-HSD1 in diabetic mice. Du H; Liu L; Wang Y; Nakagawa Y; Lyzlov A; Lutfy K; Friedman TC; Peng X; Liu Y J Mol Endocrinol; 2013 Apr; 50(2):167-78. PubMed ID: 23267038 [TBL] [Abstract][Full Text] [Related]
10. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets. Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle. Stewart PM; Toogood AA; Tomlinson JW Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348 [TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1. Molusky MM; Li S; Ma D; Yu L; Lin JD Diabetes; 2012 May; 61(5):1025-35. PubMed ID: 22447855 [TBL] [Abstract][Full Text] [Related]
14. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog. McGuinness OP; Murrell S; Moran C; Bracy D; Cherrington AD Metabolism; 1994 Oct; 43(10):1310-7. PubMed ID: 7934986 [TBL] [Abstract][Full Text] [Related]
15. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene. Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice. Zhao L; Pan Y; Peng K; Wang Z; Li J; Li D; Tong C; Wang Y; Liang G J Mol Endocrinol; 2015 Oct; 55(2):119-31. PubMed ID: 26220348 [TBL] [Abstract][Full Text] [Related]
18. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models. Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752 [TBL] [Abstract][Full Text] [Related]
19. Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans. Dufour S; Lebon V; Shulman GI; Petersen KF Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E231-5. PubMed ID: 19458062 [TBL] [Abstract][Full Text] [Related]
20. Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus. Yao F; Chen L; Fan Z; Teng F; Zhao Y; Guan F; Zhang M; Liu Y Bioorg Med Chem Lett; 2017 Sep; 27(17):4107-4113. PubMed ID: 28751144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]